Tregs, gMDSCs, and levels of soluble MICA as prognostic biomarkers for combined NEO-201 and pembrolizumab. A phase 3 study to evaluate efficacy and safety of VYD222, an IgG1 monoclonal antibody for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results